Dr. Matthew Taylor, MD

NPI: 1407430101
Total Payments
$5,688
2024 Payments
$4,748
Companies
4
Transactions
8

Payment Breakdown by Category

Research$5,540 (97.4%)
Food & Beverage$147.90 (2.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $5,540 3 97.4%
Food and Beverage $147.90 5 2.6%

Payments by Type

Research
$5,540
3 transactions
General
$147.90
5 transactions

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $5,540 3 $0 (2024)
ABIOMED $102.58 3 $0 (2024)
Boston Scientific Corporation $27.88 1 $0 (2024)
Terumo Medical Corporation $17.44 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $4,748 7 PFIZER INC. ($4,600)
2023 $940.00 1 PFIZER INC. ($940.00)

All Payment Transactions

8 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/29/2024 Boston Scientific Corporation Food and Beverage In-kind items and services $27.88 General
Category: General - EP_EP
09/19/2024 Terumo Medical Corporation NAVICROSS (Device) Food and Beverage In-kind items and services $17.44 General
Category: VASCULAR ACCESS
08/02/2024 ABIOMED Impella (Device) Food and Beverage Cash or cash equivalent $43.70 General
Category: Cardiology/Vascular Diseases
07/24/2024 ABIOMED Impella (Device) Food and Beverage Cash or cash equivalent $23.63 General
Category: Cardiology/Vascular Diseases
07/06/2024 ABIOMED Impella (Device) Food and Beverage Cash or cash equivalent $35.25 General
Category: Cardiology/Vascular Diseases
05/17/2024 PFIZER INC. MEKTOVI (Drug), BRAFTOVI In-kind items and services $1,400.00 Research
Study: BINIMETINIB CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY
03/20/2024 PFIZER INC. BRAFTOVI (Drug), MEKTOVI In-kind items and services $3,200.00 Research
Study: ENCORAFENIB PF07265807 BINIMETINIB MULTI PRODUCT CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY
06/02/2023 PFIZER INC. ELREXFIO (Drug) In-kind items and services $940.00 Research
Study: PF06804103 MAVELERTINIB PF4136309 PF06952229 NIROGACESTAT PF06671008 ARRY 382 PF04691502 PF06821497 PF06939999 PF06840003 PF07265807 COFETUZUMAB PELIDOTIN MULTI PRODUCT UTOMILUMAB GEDATOLISIB ELRANATAMAB PF067535 CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY

Research Studies & Clinical Trials

Study Name Company Amount Records
ENCORAFENIB PF07265807 BINIMETINIB MULTI PRODUCT CLINICAL PUBLICATION PROGRAM PFIZER INC. $3,200 1
BINIMETINIB CLINICAL PUBLICATION PROGRAM PFIZER INC. $1,400 1
PF06804103 MAVELERTINIB PF4136309 PF06952229 NIROGACESTAT PF06671008 ARRY 382 PF04691502 PF06821497 PF06939999 PF06840003 PF07265807 COFETUZUMAB PELIDOTIN MULTI PRODUCT UTOMILUMAB GEDATOLISIB ELRANATAMAB PF067535 CLINICAL PUBLICATION PROGRAM PFIZER INC. $940.00 1

About Dr. Matthew Taylor, MD

Dr. Matthew Taylor, MD is a Internal Medicine healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2021. The National Provider Identifier (NPI) number assigned to this provider is 1407430101.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Taylor, MD has received a total of $5,688 in payments from pharmaceutical and medical device companies, with $4,748 received in 2024. These payments were reported across 8 transactions from 4 companies. The most common payment nature is "" ($5,540).

Practice Information

  • Specialty Internal Medicine
  • Location Orlando, FL
  • Active Since 05/09/2021
  • Last Updated 09/17/2025
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1407430101

Products in Payments

  • BRAFTOVI (Drug) $3,200
  • MEKTOVI (Drug) $1,400
  • ELREXFIO (Drug) $940.00
  • Impella (Device) $102.58
  • NAVICROSS (Device) $17.44

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Orlando